ATE302609T1 - Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii - metallverbindungen - Google Patents

Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii - metallverbindungen

Info

Publication number
ATE302609T1
ATE302609T1 AT98954635T AT98954635T ATE302609T1 AT E302609 T1 ATE302609 T1 AT E302609T1 AT 98954635 T AT98954635 T AT 98954635T AT 98954635 T AT98954635 T AT 98954635T AT E302609 T1 ATE302609 T1 AT E302609T1
Authority
AT
Austria
Prior art keywords
bil
components
group
metal compounds
lowering blood
Prior art date
Application number
AT98954635T
Other languages
English (en)
Inventor
Alun Roy Williams
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE302609T1 publication Critical patent/ATE302609T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98954635T 1997-11-26 1998-11-18 Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii - metallverbindungen ATE302609T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724840.5A GB9724840D0 (en) 1997-11-26 1997-11-26 Reduced blood cholesterol
PCT/GB1998/003475 WO1999026638A1 (en) 1997-11-26 1998-11-18 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances

Publications (1)

Publication Number Publication Date
ATE302609T1 true ATE302609T1 (de) 2005-09-15

Family

ID=10822574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954635T ATE302609T1 (de) 1997-11-26 1998-11-18 Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii - metallverbindungen

Country Status (7)

Country Link
EP (1) EP1032406B1 (de)
JP (1) JP2001523725A (de)
AT (1) ATE302609T1 (de)
DE (1) DE69831348T2 (de)
ES (1) ES2247725T3 (de)
GB (1) GB9724840D0 (de)
WO (1) WO1999026638A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
DE69413544T2 (de) * 1993-08-24 1999-05-27 Kappa Pharmaceuticals Ltd., Reading Reduzierte absorption von fettsäuren

Also Published As

Publication number Publication date
DE69831348T2 (de) 2006-06-22
WO1999026638A1 (en) 1999-06-03
GB9724840D0 (en) 1998-01-21
EP1032406B1 (de) 2005-08-24
DE69831348D1 (de) 2005-09-29
JP2001523725A (ja) 2001-11-27
ES2247725T3 (es) 2006-03-01
EP1032406A1 (de) 2000-09-06

Similar Documents

Publication Publication Date Title
DE69626660D1 (en) 2-alkylpyrrolidine
IL142824A0 (en) Lipoic acid derivatives and their use in treatment of disease
EP0684592A3 (de) Elektronisches Tagebuch.
DE69431660D1 (de) 2-pyridylmethylen-polyazamacrocyclophosphonsäuren, ihre komplexe und derivate zur verwendung als kontrastmittel
DZ2953A1 (fr) Méthodes de réduction des niveaux de glucose et triglycérides en sérum et pour suppression de l'anti-genèse utilisant les acides la indoleakanoique.
DE69525747D1 (de) Implantierbare kapsel zur hervorhebung der zellpotentiale
EP1857113A3 (de) Verfahren und Materialien zur Behandlung von Asthma
ZA951295B (en) 6-substituted mycophenolic acid and derivatives
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
PT1427409E (pt) Métodos para tratar ou para impedir a inflamação vascular utilizando inibidor(es) de absorção de esteróis
TR199802441A3 (tr) Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip.
DE69512898D1 (de) Hochfeste lötlegierung
DE69719957D1 (de) Schwefelbeständige NOx-Falle enthaltend Wolframphorsphorsäure und Edelmetalle
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
ZA992192B (en) Humectant and lubricant solution for ophthalmic use.
ATE302609T1 (de) Blutcholesterinsenkung durch die in vivo fällung von gallenbestandteilen mit gruppe ii oder -iii - metallverbindungen
DE59605429D1 (de) Anode zur elektrolytischen Gewinnung von Metallen
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
ZA989884B (en) Metal treatment liquid for the neutral PH range
IL135499A0 (en) Bile acid salts of metals with physiogical action and use thereof in theraphy
WO2002038566A3 (en) Carbene porphyrins and carbene porphyrinoids for use in medical diagnosis and treatment
NZ514691A (en) Method to type prion proteins
IL161388A0 (en) Method of reducing type 2 diabetes in high risk patients
AU2002319080A1 (en) Method for the diagnosis and therapy of renal cell carcinoma
WO1998038356A3 (de) Verfahren und vorrichtung zum herstellen einer elektrodenschicht

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties